Objectives. To evaluate prospectively the ability of two equations tha
t we previously derived to predict maintenance theophylline dosages th
at provide a serum theophylline concentration (STC) of 8 mu g/ml, the
midtherapeutic range for treating apnea of prematurity; and to determi
ne the number of further dosage adjustments and STC determinations req
uired to achieve the target concentration in infants in whom it was no
t achieved initially. Design. Prospective study. Setting. A 37-bed neo
natal intensive care unit. Patients. Fifty-four infants 27-34 weeks' g
estational age requiring intravenous hydrous aminophylline. Interventi
ons. Patients received a loading dose of 6 mg/kg intravenous aminophyl
line, followed by a maintenance dosage calculated using one of the two
derived equations. The basis for equation selection was the gestation
al age of the patient. Measurements and Main Results. Patients were st
ratified into two age groups: 27-30 weeks' gestational age (34 infants
) and 31-34 weeks' gestational age (20 infants). The overall success r
ate for both equations in achieving the target concentration was 74%.
When infants were stratified by gestational age, those dosed by Equati
on 1 had a 76% success rate and those dosed by Equation 2 had a 65% su
ccess rate. Overall, 14 of 54 infants received an average of 1.2 dosag
e adjustments. This represents more than a 50% reduction in the number
of adjustments made before introduction of these equations. Conclusio
ns. The ability of our previously derived equations to produce an STC
within the midtherapeutic range for treating apnea of prematurity was
demonstrated in the majority of patients studied (74%). Further, the n
umber of subsequent dosage adjustments required to attain the target S
TC in infants who had failed to achieve this STC initially was signifi
cantly less than using older, more traditional regimens.